470 related articles for article (PubMed ID: 25568448)
1. Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants.
Duclot F; Kabbaj M
J Exp Biol; 2015 Jan; 218(Pt 1):21-31. PubMed ID: 25568448
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of BDNF in the learned helplessness-induced animal model of depression.
Su CL; Su CW; Hsiao YH; Gean PW
J Psychiatr Res; 2016 May; 76():101-10. PubMed ID: 26921875
[TBL] [Abstract][Full Text] [Related]
3. Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients.
Kao CF; Liu YL; Yu YW; Yang AC; Lin E; Kuo PH; Tsai SJ
Sci Rep; 2018 May; 8(1):6983. PubMed ID: 29725086
[TBL] [Abstract][Full Text] [Related]
4. Alleviative effects of fluoxetine on depressive-like behaviors by epigenetic regulation of BDNF gene transcription in mouse model of post-stroke depression.
Jin HJ; Pei L; Li YN; Zheng H; Yang S; Wan Y; Mao L; Xia YP; He QW; Li M; Yue ZY; Hu B
Sci Rep; 2017 Nov; 7(1):14926. PubMed ID: 29097744
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: insights in depression.
Ignácio ZM; Réus GZ; Abelaira HM; Quevedo J
Neuroscience; 2014 Sep; 275():455-68. PubMed ID: 24972302
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood?
Nair A; Vaidya VA
J Biosci; 2006 Sep; 31(3):423-34. PubMed ID: 17006024
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant and neuroprotective effect of the Chinese herb kaixinsan against lentiviral shRNA knockdown brain-derived neurotrophic factor-induced injury in vitro and in vivo.
Hu Y; Zhou XJ; Liu P; Dong XZ; Mu LH; Chen YB; Liu MY; Yu BY
Neuropsychobiology; 2014; 69(3):129-39. PubMed ID: 24776773
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Modifications of Major Depressive Disorder.
Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of genetic and epigenetic mechanisms that regulate BDNF expression and function with relevance to major depressive disorder.
Hing B; Sathyaputri L; Potash JB
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):143-167. PubMed ID: 29243873
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models.
Chistiakov DA; Bobryshev YV; Chekhonin VP
Curr Pharm Des; 2017; 23(44):6828-6840. PubMed ID: 29086676
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA‑132 in rats with depression.
Su M; Hong J; Zhao Y; Liu S; Xue X
Mol Med Rep; 2015 Oct; 12(4):5399-406. PubMed ID: 26239616
[TBL] [Abstract][Full Text] [Related]
13. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression.
Hashimoto K
Prog Neurobiol; 2013 Jan; 100():15-29. PubMed ID: 23044468
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics and depressive disorders: a review of current progress and future directions.
Januar V; Saffery R; Ryan J
Int J Epidemiol; 2015 Aug; 44(4):1364-87. PubMed ID: 25716985
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
Tsai SJ; Hong CJ; Liou YJ
Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861
[TBL] [Abstract][Full Text] [Related]
16. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
Tsai SJ
Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
[TBL] [Abstract][Full Text] [Related]
17. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
[TBL] [Abstract][Full Text] [Related]
18. [Epigenetic mechanism of major depression].
Morinobu S
Seishin Shinkeigaku Zasshi; 2013; 115(11):1101-12. PubMed ID: 24450142
[TBL] [Abstract][Full Text] [Related]
19. New insights on brain-derived neurotrophic factor epigenetics: from depression to memory extinction.
Poon CH; Heng BC; Lim LW
Ann N Y Acad Sci; 2021 Jan; 1484(1):9-31. PubMed ID: 32808327
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene.
Wei Y; Melas PA; Wegener G; Mathé AA; Lavebratt C
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25618518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
